Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: Real-world Experience of ICIs Plus Chemotherapy for Advanced ESCC.

View source ↗

Summary

A completed real-world study examining immune checkpoint inhibitors combined with chemotherapy for advanced/metastatic esophageal squamous cell carcinoma, spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fudan University | Conditions: Metastatic Esophageal Squamous Cell Carcinoma | Status: COMPLETED